HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 293/2/F555    most recent 00403.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Lenderink, A. M. Articles by Thurman, J. M. Search for Related Content PubMed PubMed Citation Articles by Lenderink, A. M. Articles by Thurman, J. M.

The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy

Amanda M. Lenderink,¹ Katharine Liegel,¹ Danica Ljubanovi,² Kathrin E. Coleman,¹ Gary S. Gilkeson,³ V. Michael Holers,¹ and Joshua M. Thurman¹

¹Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado; ²Department of Pathology, University Hospital Dubrava, Zagreb, Croatia; ³Department of Medicine, Medical University of South Carolina and Medical Research Service, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina

Submitted 12 October 2006 ; accepted in final form 11 May 2007

The complement system effectively identifies and clears invasive pathogens as well as injured host cells. Uncontrolled complement activation can also contribute to tissue injury, however, and inhibition of this system may ameliorate many types of inflammatory injury. Several studies have demonstrated that the filtration of complement proteins into the renal tubules, as occurs during proteinuric renal disease, causes tubular inflammation and injury. In the present study, we tested the hypothesis that activation of the complement system in the urinary space requires an intact alternative pathway. Using a model of adriamycin-induced renal injury, which induces injury resembling focal segmental glomerulosclerosis, we examined whether mice deficient in factor B would be protected from the development of progressive tubulointerstitial injury. Complement activation was attenuated in the glomeruli and tubulointerstitium of mice with congenital deficiency of factor B (fB–/–) compared with wild-type controls, demonstrating that complement activation does occur through the alternative pathway. Deficiency in factor B did not significantly protect the mice from tubulointerstitial injury. However, treatment of wild-type mice with an inhibitory monoclonal antibody to factor B did delay the development of renal failure. These results demonstrate that complement activation in this nonimmune complex-mediated model of progressive renal disease requires an intact alternative pathway.

proteinuria

This article has been cited by other articles:

				Z. Tang, B. Lu, E. Hatch, S. H. Sacks, and N. S. Sheerin C3a Mediates Epithelial-to-Mesenchymal Transition in Proteinuric Nephropathy J. Am. Soc. Nephrol., March 1, 2009; 20(3): 593 - 603. [Abstract] [Full Text] [PDF]

				J. W. Pippin, P. T. Brinkkoetter, F. C. Cormack-Aboud, R. V. Durvasula, P. V. Hauser, J. Kowalewska, R. D. Krofft, C. M. Logar, C. B. Marshall, T. Ohse, et al. Inducible rodent models of acquired podocyte diseases Am J Physiol Renal Physiol, February 1, 2009; 296(2): F213 - F229. [Abstract] [Full Text] [PDF]